Avidity Partners Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Avidity Partners Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,215,500	Closed	-$113M	–	117
2021 Q4	$113M	Buy	1,215,500 +76,500	+7%	+$5.04M	2.4%	13
2021 Q3	$67.8M	Buy	1,139,000 +196,000	+21%	+$11.6M	1.5%	23
2021 Q2	$64.3M	Buy	943,000 +44,450	+5%	+$2.9M	1.74%	18
2021 Q1	$62.4M	Buy	898,550 +277,550	+45%	+$21.4M	1.72%	18
2020 Q4	$47.7M	Buy	+621,000	New	+$46.5M	1.55%	18

Avidity Partners Management's ARNA Position: Q1 2022 in Review

Avidity Partners Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 1,215,500 shares — an estimated $113M sold.

Avidity Partners Management first reported a position in ARNA in Q4 2020 and held it in 5 quarters. The position peaked at $113M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Avidity Partners Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Avidity Partners Management sold 1,215,500 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $113M.
Avidity Partners Management first reported a position in Arena Pharmaceuticals Inc in Q4 2020 and held it in 5 quarters.
Avidity Partners Management's Arena Pharmaceuticals Inc position peaked at $113M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Avidity Partners Management's 13F filing for Q1 2022, filed 16 May 2022.